Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Construct Validity and Reliability SCUES

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03600597
Recruitment Status : Completed
First Posted : July 26, 2018
Last Update Posted : July 27, 2018
Sponsor:
Information provided by (Responsible Party):
Ayse Simsek, Gazi University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of the study was to determine construct validity, discriminant validity and intra- and interrater reliability of the Selective Control of the Upper Extremity Scale (SCUES).

Condition or disease
Cerebral Palsy Upper Extremity Dysfunction

Detailed Description:
This study included children diagnosed with unilateral cerebral palsy. Children's upper extremity-selective motor controls were evaluated by video recording. Manual Ability Classification System and Taylor Hand Function Test were used to determine upper extremity functions
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 33 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Construct Validity and Reliability of the Selective Control of the Upper Extremity Scale in Children With Cerebral Palsy
Actual Study Start Date : April 10, 2017
Actual Primary Completion Date : March 10, 2018
Actual Study Completion Date : May 10, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cerebral Palsy

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Selective Control of the Extremity Scale [ Time Frame: 10 minutes ]
    SCUES administration required patients to perform specific isolated movement patterns at the shoulder (abduction/adduction), elbow (flexion/extension), forearm (supination/pronation), wrist (flexion/extension), and fingers/ thumb (grasp/release). Presence of mirror movements, movement of additional joints and motion less than available ROM are graded for movement at each joint level. Motion at each of the five joint levels is graded on a four-point scale: no SMC, moderately diminished SMC, mildly diminished SMC, and normal SMC.


Secondary Outcome Measures :
  1. Jebsen Taylor Hand Function Test [ Time Frame: 20 minutes ]
    The JTT measures movement, speed and manual dexterity. The subtests to assess hand function included turning over cards, simulated feeding, picking up small common objects, stacking checkers, picking up large objects, and picking up large heavy objects. Each task completion time was limited to 2 minutes.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   3 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Children with Unilateral Cerebral Play
Criteria

Inclusion Criteria:

  • Ages between 3-18 years
  • Diagnosed as Cerebral Palsy (Hemiplegia)

Exclusion Criteria:

  • Participants with an unstable situation regarding their tonus-regulating medications
  • Participants had a botulinum toxin injection within the last 6 months, or any surgical correction within the last year
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03600597


Locations
Layout table for location information
Turkey
Gazi University
Ankara, Yeni̇mahalle, Turkey, 06560
Sponsors and Collaborators
Gazi University
Investigators
Layout table for investigator information
Study Chair: Bulent Elbasan Study chair
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Ayse Simsek, Research assistant, Gazi University
ClinicalTrials.gov Identifier: NCT03600597    
Other Study ID Numbers: 77082166-302.08.01-
First Posted: July 26, 2018    Key Record Dates
Last Update Posted: July 27, 2018
Last Verified: July 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases